Skip to content

Cerebrolysin

Research Use Only
blendIM

Brain-repair peptide blend from pig brain tissue containing natural nerve growth factors. Used for stroke and TBI recovery in 50+ countries. Strongest RCT evidence of any brain peptide.

Key Facts

  • Classification
    Cerebrolysin is a porcine brain-derived peptide preparation of low-molecular-weight neuropeptides.
  • Primary Benefits
    Brain & Cognition (10/10) · Injury Healing (6/10) · Mood & Anxiety (4/10)
  • Administration
    IM
  • Typical Dose
    5 mL intramuscular (IM) daily, or larger doses via IV infusion, for 10-20 days. NOT administered subcutaneously. Specific protocols vary depending on the condition being treated.
  • Evidence Strength
    Moderate — 20 peer-reviewed studies referenced · Community sentiment 8/10
  • Stacks Well With
    Semax, Dihexa, Selank, SS-31
  • Legal Status
    Research Use Only · not prescribable in US

Quick Facts

From price
$60
Type
blend
Administration
IM
Evidence
moderate
Studies referenced
20
Community sentiment
8/10
Stacks with
4 peptides
Regulatory
Research Use Only

Top benefits

🧠 Brain & Cognition
10/10
🩹 Injury Healing
6/10
😌 Mood & Anxiety
4/10
1

Week 1–2

Subtle cognitive improvements may begin. Enhanced verbal fluency reported anecdotally. Neurotrophic effects beginning at cellular level. Clinical trial benefits for stroke typically emerge over longer periods.

2

Week 3–6

Significant cognitive enhancement — memory, learning speed, and mental stamina. Improved neuroplasticity. Better stress resilience.

3

Week 8+

Sustained neuroprotective benefits. Long-term cognitive gains, especially in age-related decline. Cumulative neurotrophic effects support ongoing brain health.

Common Side Effects

Injection site reactionsHeadacheDizzinessAgitation (rare)Mild nauseaInsomnia if dosed late in day
Tolerance: Not well-characterized — neurotrophic effects appear cumulative
Cycling: 10-20 day intensive cycles (IM or IV daily), 2-4 times per year. Rest 2-3 months between cycles.

Scientific Overview

Cerebrolysin is a porcine brain-derived peptide preparation of low-molecular-weight neuropeptides. Mimics BDNF, GDNF, and CNTF signaling. CASTA trial (n=1,070) showed improved neurological outcomes when administered within 72 hours of stroke. Approved in 50+ countries.

Dosing

5 mL intramuscular (IM) daily, or larger doses via IV infusion, for 10-20 days. NOT administered subcutaneously. Specific protocols vary depending on the condition being treated.

Reconstitution, storage, injection sites & timing

Benefit Profile

🧠 Brain & Cognition
10/10
🩹 Injury Healing
6/10
😌 Mood & Anxiety
4/10
Longevity
3/10
Medical oversight requiredNot safe during pregnancy· 4 contraindications